Distalmotion

Distalmotion (#LSIAlumni) has been granted De Novo approval by the FDA to market the Dexter Surgical Robot for adult inguinal hernia repair. The company is focused on developing a robotic platform for high-volume procedures and bringing the benefits of robotic-assisted surgery to outpatient settings where demand for cost-effective and efficient solutions continue to grow. With more than 1,300 patients successfully treated in Europe, Distalmotion’s extensive experience has paved the way for bringing this innovation to the U.S. market. Dexter integrates seamlessly into existing operating room workflows, is fully compatible with current OR equipment, and offers single-use instruments to simplify reprocessing. Its design provides direct and quick access to the patient, giving surgeons the flexibility to choose the optimal technique for each step of the procedure. Congratulations to LSI Alumni Greg Roche and the Distalmotion team on this major milestone! To hear more, check out Greg Roche’s full presentation from LSI USA '24 on our website and YouTube channel, and meet him this March at LSI USA '25, where he’s set to present the latest updates.

Distalmotion’s #Dexter platform gets FDA Clearance. The momentum continues in the soft tissue surgical robotics market. Dexter receives clearance on inguinal hernia as its first indication. Distalmotion's CEO Greg Roche joined me on set with the Dragonfly - A TMG Company team to break the news at One60Studios, and we discuss how the Dexter platform empowers healthcare facilities with a robotic solution that addresses the barriers of cost, space, and workflow that will open new markets and sites of care bringing much-needed accessibility to market and the benefits of robotic surgery to more patients. Full session in comments.

Today, we are proud to announce that #Dexter has received marketing authorization for inguinal hernia repair in the U.S. This milestone brings us closer to making robotic surgery more accessible to patients worldwide. “We’re excited to bring Dexter to the U.S. market and empower healthcare facilities with a robotic solution that addresses the barriers of cost, space, and workflow disruption. Our goal is to enhance existing practices with robotics that support—not disrupt—the way surgical teams operate.”   - Greg Roche, Distalmotion CEO Learn more here: https://lnkd.in/gfjfuzYr   #FDAAuthorization #RoboticAssistedSurgery #HealthcareInnovation #HOPD #ASC   #Distalmotion #EmpoweringRoboticSurgery #Simplicity #Accessibility #Excellence

We are excited to announce that the #Dexter Surgical Robot has received FDA marketing authorization for inguinal hernia repair in the U.S.  This marks a major step in our mission to empower robotic surgery by expanding access to more patients and healthcare providers, especially in outpatient settings and Ambulatory Surgery Centers (ASCs). Dexter's small format, mobile design, and open platform make it a perfect fit for high-volume procedures in all sites of care—helping surgeons optimize resources while accessing the benefits of robotic surgery excellence. A special thank you to our EU partners for your unwavering support and partnership, which has been instrumental in paving the way for Dexter’s expansion into the U.S. market. Read more here: https://lnkd.in/eJDz9eNk The Dexter System is intended for use in laparoscopic inguinal hernia repair. The system is indicated for adult uses, as defined as 22 years old and older.     #FDAAuthorization #RoboticSurgery #HealthcareInnovation #HOPD #ASC #Distalmotion #EmpoweringRoboticSurgery #Simplicity #Accessibility #Excellence 

🎉World's first liver surgery🎉 performed with #Dexter Prof. Stefan Breitenstein and Dr. Nico Seeger have successfully completed a #liver surgery at Kantonsspital Winterthur in Switzerland. We are proud to see Dexter making robotic surgery more accessible. Learn more about the #simplicity, #accessibility and #excellence of Dexter in modern minimal-invasive robotic surgery - https://lnkd.in/dgGfjvhi #Distalmotion #EmpoweringRoboticSurgery

Surgical Trend Spotlight The migration of procedures to Ambulatory Surgery Centers (ASCs) has sparked growing interest in performing robotic-assisted surgery (RAS) in an outpatient setting. For success in this environment, solutions must address a distinct set of requirements. #AmbulatorySurgeryCenters #OutpatientCare #RAS 

Surgical Trend Spotlight Established in 1970 to overcome the challenges associated with inpatient surgeries, Ambulatory Surgery Centers (ASCs) continue to drive the shift toward more procedures being performed in outpatient settings. #AmbulatorySurgeryCenters #OutpatientCare

We’re excited to be attending ESGE - European Society for Gynaecological Endoscopy next week from Oct 27 – 30, in Marseille. Interested in a hands-on demonstration with #Dexter? Sign up here 🔗: https://lnkd.in/eZaHbXwP Learn more about the #simplicity, #accessibility and #excellence of Dexter in gynecological surgery. #roboticsurgery #innovation #distalmotion #surgicalrobotics #gynecology #endoscopy

We are delighted to partner with IRCAD for our upcoming #webinar on Dexter in colorectal robotic surgery! Register now 🔗: https://lnkd.in/dJapQZ4u Learn how leading hospitals are integrating #Dexter into their daily practice. 🗓️ Date: 13 November 2024 ⏰ Time: 17:00 – 18:00 CET 🎓 Accredited by SGC / SSC Schweizerische Gesellschaft für Chirurgie for 1 CME Point. A certificate of attendance will be issued after the event. In this exclusive webinar, you'll hear from experts in robotic-assisted colorectal surgery who will share their experiences and insights on: 👉 Implementation of the CME right hemicolectomy with Dexter: Lessons learned 👉 Our robotic approach to sigmoidectomy with Dexter 👉 Implementing Dexter into a minimally invasive visceral surgery program at a public hospital Don't miss this opportunity to gain valuable insights, engage with Dexter users, and ask your questions in the live Q&A session! University Hospital Schleswig-Holstein (UKSH) Kantonsspital Winterthur Proximie #RoboticSurgery #ColorectalSurgery #CME #MedicalWebinar #SurgicalInnovation #Healthcare #Distalmotion #EmpoweringRoboticSurgery

Distalmotion's CEO, Greg Roche, presents at AdvaMed's The MedTech Conference during Truist's Disruptor Showcase on Dexter's innovation and growth strategy. #MedTechCon #MTC24 #dexter